Active	Status	Sponsor type	Region	Phase	Filter
7 Active 5 Inactive 12 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kalman, Jonathan M
OCEAN, NCT02168829: Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial	Active, not recruiting	4	1284	Europe, Canada, RoW	Rivaroxaban, Xarelto, Acetylsalicylic acid, Aspirin, ASA	Ottawa Heart Institute Research Corporation, Canadian Institutes of Health Research (CIHR), Bayer, Biotronik Canada Inc	Atrial Fibrillation, Stroke	07/25	08/25
NCT06223789: VOLT-AF IDE Clinical Study	Recruiting	N/A	435	Europe, Canada, US, RoW	Pulsed Field Ablation	Abbott Medical Devices	Atrial Arrhythmia, Atrial Fibrillation, Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation	01/26	01/26
Royse, Alistair
SURE-AVR, NCT02679404: Sorin Universal REgistry on Aortic Valve Replacement	Terminated	N/A	2758	Europe, Canada, US, RoW		Corcym S.r.l	Aortic Valve Disease, Aortic Stenosis	03/21	03/21
Ward, Juliet
No trials found
Williams, Zelda
No trials found